Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PD-1 blockade as bridge to allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series.
Casadei B, Broccoli A, Stefoni V, Pellegrini C, Marangon M, Morigi A, Nanni L, Lolli G, Carella M, Argnani L, Cavo M, Zinzani PL. Casadei B, et al. Among authors: carella m. Haematologica. 2019 Nov;104(11):e521-e522. doi: 10.3324/haematol.2019.215962. Epub 2019 Mar 19. Haematologica. 2019. PMID: 30890595 Free PMC article. No abstract available.
90 Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study.
Lolli G, Argnani L, Broccoli A, Marangon M, Pellegrini C, Morigi A, Casadei B, Nanni L, Stefoni V, Carella M, Cavo M, Zinzani PL. Lolli G, et al. Among authors: carella m. Br J Haematol. 2020 Apr;189(1):e6-e9. doi: 10.1111/bjh.16404. Epub 2020 Jan 13. Br J Haematol. 2020. PMID: 31944265 Free article. Clinical Trial. No abstract available.
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience.
Casadei B, Argnani L, Morigi A, Lolli G, Broccoli A, Pellegrini C, Nanni L, Stefoni V, Coppola PE, Carella M, Cavo M, Zinzani PL. Casadei B, et al. Among authors: carella m. Hematol Oncol. 2020 Dec;38(5):737-741. doi: 10.1002/hon.2803. Epub 2020 Sep 30. Hematol Oncol. 2020. PMID: 32905626
409 results